Browsing Tag
Corcept Therapeutics Incorporated
7 posts
Corcept Therapeutics (CORT) CATALYST data puts Korlym at centre of difficult-to-control diabetes strategy
Find out how Corcept Therapeutics’ ADA data could reshape cortisol screening in hard-to-control diabetes and GLP-1 care.
Corcept Therapeutics (CORT) stock in focus as ROSELLA survival data strengthen Lifyorli launch in ovarian cancer
Corcept Therapeutics strengthened its Lifyorli launch with new ROSELLA survival data. Read what this means for CORT stock and ovarian cancer treatment.
Corcept Therapeutics (NASDAQ: CORT) puts resistant hypertension in the cortisol spotlight with new MOMENTUM trial data
Corcept Therapeutics says 27.3% of resistant hypertension patients may have hypercortisolism. Read what the MOMENTUM data could mean next.
Corcept Therapeutics (NASDAQ: CORT) plunges as FDA rejects relacorilant for Cushing’s-related hypertension therapy
Corcept shares nosedive after FDA rejection of relacorilant for Cushing’s syndrome-related hypertension. Find out what this means for the company’s future.
MicroAlgo crashes 20%, Trump Media slips again—here’s why markets panicked
Explore why 25 top U.S.-listed stocks tumbled on April 2 as Trump’s tariff strategy ignited fears of inflation, recession, and global retaliation.
Why did Corcept, Johnson & Johnson, and Southwest Airlines fall on April 1, 2025?
Corcept, Johnson & Johnson, and Southwest Airlines lead US stock losses as biotech and airline sectors react to trade policy jitters on April 1, 2025.
U.S. stock market gainers on March 31: Corcept, MicroAlgo, and Mr. Cooper surge amid economic uncertainty
The U.S. stock market saw a mix of volatility and strong gains on March 31, 2025, as investors…